Skip to main content

Concept to Clinic: Commercializing Innovation (C3i) Program | National Institute of Biomedical Imaging and Bioengineering

By June 17, 2019News
nhlbi-nih-logo

nhlbi-nih-logo

The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.

{iframe}https://www.nibib.nih.gov/research-funding/concept-clinic-commercializing-innovation-c3i-program{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.